$822 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 62 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GTYH | GTY TECHNOLOGY HOLDINGS INC | $8,720,000 | +5.8% | 1,159,600 | 0.0% | 1.06% | +11.1% | |
| SLGL | SOL GEL TECHNOLOGIES | $8,328,000 | -19.2% | 832,800 | 0.0% | 1.01% | -15.2% | |
| GNCA | GENOCEA BIOSCIENCES INC | $3,786,000 | -18.0% | 1,972,056 | 0.0% | 0.46% | -13.8% | |
| SCYX | SCYNEXIS INC | $3,376,000 | -28.0% | 637,048 | 0.0% | 0.41% | -24.3% | |
| TMQ | TRILOGY METALS INC NEW | $3,096,000 | -26.3% | 1,673,461 | 0.0% | 0.38% | -22.6% | |
| MSAC | MEDICUS SCIENCES ACQUISITION | $2,925,000 | +1.0% | 300,000 | 0.0% | 0.36% | +6.3% | |
| GEG | GREAT ELM GROUP INC | $2,820,000 | -0.5% | 1,259,049 | 0.0% | 0.34% | +4.6% | |
| NAPA | DUCKHORN PORTFOLIO INC | $2,678,000 | +3.8% | 117,000 | 0.0% | 0.33% | +9.0% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $1,956,000 | -0.7% | 200,000 | 0.0% | 0.24% | +4.4% | |
| IFRX | INFLARX NV | $1,036,000 | -12.8% | 400,000 | 0.0% | 0.13% | -8.7% | |
| XCUR | EXICURE INC | $407,000 | -20.0% | 339,395 | 0.0% | 0.05% | -15.3% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $48,000 | -30.4% | 66,665 | 0.0% | 0.01% | -25.0% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $22,000 | -35.3% | 33,332 | 0.0% | 0.00% | -25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.